Results 301 to 310 of about 260,498 (362)

Prevalence and correlates of hyperbilirubinemia among people living with HIV (PLHIV) receiving atazanavir boosted with ritonavir (ATV/r). [PDF]

BMC Gastroenterol
Farrokhi H, Shahmohamadi E, Pashaei A, Emadi Koochak H, Nooralioghli Parikhani S, Fathi Amrollah M, Mirzapour P, Dehghan Manshadi SA, SeyedAlinaghi S, Hackett D.   +9 more
europepmc   +1 more source

Molecular Epidemiological Surveillance of HIV-1 Genotypes and Drug Resistance Profiles in Wuhan, Central China. [PDF]

Viruses
Zhang Q, Yan M, Huang J, Liu Y, Wang H, Feng S, Dong Z, Abulimiti D, Wang Y, Liang K, Feng Y.   +10 more
europepmc   +1 more source

Accessing HIV Care to Irregular Migrants in Israel, 2019-2024. [PDF]

Viruses
Wagner T, Mor Z, Dickstein Y, Turner D, Kedem E, Levy I, Wieder-Finesod A, Elinav H, Eddin IN, Olshtain-Pops K, Elbirt D, Smolyakov R, Istomin V, Wax M, Gozlan Y, Mor O.   +15 more
europepmc   +1 more source

Prevalence of primary HIV-1 drug resistance among antiretroviral-naïve individuals in Togo in 2023: a national study. [PDF]

Front Public Health
Ouro-Medeli A, Togan RM, Serrano L, Butel C, Atoun R, Youa F, Ali-Edje K, Douffan M, Ehlan P, Tegueni K, Amenti R, Konou AA, Salou M, Ekouevi DK, Peeters M, Dagnra AC.   +15 more
europepmc   +1 more source

Structure-Guided Design of Peptide Inhibitors Targeting Class I Viral Fusion Proteins. [PDF]

Pathogens
Gonepudi NK, Baffour Awuah H, Xu W, Katte RH, Lu M.   +4 more
europepmc   +1 more source

Darunavir analog precursors target mitochondrial metabolism in multiple myeloma and CLL. [PDF]

Cancer Cell Int
Mecca M, Sichetti M, Spina E, Giuseffi M, Giglio E, Picerno S, Valvano L, Statuto T, Santarsiere A, Funicello M, Armentano MF, Chiummiento L, Lupattelli P, Romano A, Giordano A, Cortellino S.   +15 more
europepmc   +1 more source

Tracking the evolution of multiple in vitro HCV replicon mutants under protease inhibitor selection pressure by 454 ultra deep sequencing. [PDF]

Claes, Marijke, Fanning, G, Lenz, O, Neyts, Johan, Simmen, K, Van Marck, H, Vandenbroucke, I, Verbinnen, T, Vijgen, L   +8 more
core  

Evaluating HIV-1 Transmitted Drug Resistance and Clustering in Newly Diagnosed Patients in Romania (2019-2022). [PDF]

Viruses
Banica L, Hohan R, Nicolae I, Patrascu R, Casangiu C, Paraschiv S, Lazureanu VE, Profir VB, Paraskevis D, Otelea D.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

HIV-Protease Inhibitors

New England Journal of Medicine, 1998
Inhibitors of human immunodeficiency virus (HIV)–encoded protease, combined with nucleoside analogues with antiretroviral activity, cause profound and sustained suppression of viral replication, reduce morbidity, and prolong life in patients with HIV infection.1–3 Recent guidelines recommend that initial treatment of all HIV-infected patients include ...
G. Di Perri, P. Del Bravo, CONCIA, Ercole   +2 more
semanticscholar   +6 more sources